Nora Brennan

Nora Brennan is an accomplished financial executive with extensive experience in leadership roles within the biotechnology and pharmaceutical sectors. Currently serving as a Member of the Board of Directors and Audit Chair at Artios, Nora has held the position of Chief Financial Officer at several companies, including Spectrum Pharmaceuticals, Inc., Fore Biotherapeutics, TELA Bio, and Xeris Pharmaceuticals, Inc. Academic credentials include an MBA in Finance and Accounting from The University of Chicago Booth School of Business and a BA in Economics from the University of Illinois Urbana-Champaign.